Biolex files for IPO
Biolex, Inc. Files for $70 Million IPO
8/14/2007
RESEARCH TRIANGLE PARK, NC--(MARKET WIRE)--Aug 14, 2007 -- Biolex, Inc. today announced that it has filed a registration statement with the Securities and Exchange Commission relating to the proposed initial public offering of its common stock. The number of shares of common stock to be offered, all of which are expected to be offered by Biolex, and the price range for the offering, have not yet been determined. Biolex expects to use the net proceeds from the offering to fund clinical trials, preclinical testing and other research and development activities, and for general and administrative expenses, working capital needs and other general corporate purposes.
Lehman Brothers Inc. and Deutsche Bank Securities Inc. are acting as joint book-running managers and Leerink Swann & Co., Inc. is acting as co-manager for the offering.
Market Data 
Markets 
AI
